Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series

Karen Wong, Houda Al-Amri, Ana Werlang · 2026

Read Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series by Karen Wong, Houda Al-Amri, Ana Werlang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13310638.txt.

Description

Karen Wong and co-authors gather pregnancy outcomes after hormone-mimicking diabetes drug exposure in a 2026 case series. Drugs in the GLP-1 class improve blood sugar and weight, which can restore fertility, so unplanned pregnancies during use are growing more common. Safety data for early pregnancy exposure stay thin.

Records covered 16 patients at a large perinatal center who used the drugs from two months before conception into early pregnancy. All pregnancies were unplanned singletons, all patients used injected semaglutide into part of the first trimester, and all were overweight or obese at baseline in the series. No major fetal anomalies were found, and no patient lost weight during pregnancy. The authors add the series to counseling evidence.

Catalog record

CREATORKaren Wong, Houda Al-Amri, Ana Werlang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12614
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13310638

Browse the full library · About the Tower of Babel